Adam Ang
It will use its fresh funds to complete a multi-site validation study across eight Asia-Pacific markets.
This comes after it launched its CDI tool called DxPrime in June.
It claims to help people stop smoking in four weeks.
It is a home-based programme with 10 self-paced modules.
Dozee's sensor-based technology uses AI to track vital parameters.
One of the projects will develop a digital navigator to support people with chronic conditions.
It will be used to accelerate collaborations with pharmaceutical firms.
It will use its latest funds for its global expansion.
Also, scientists from the University of South Australia have developed tiny fibre sensors for remote patient monitoring.
Also, CureApp is getting $77 million in investment from the Sawai Group as part of their license deal.